{"text": "#bristolmyerssquibb bristol-myers squibb enters into separate agreements with biogen and roc... read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristol-myers squibb enters into separate agreements with biogen and roc... read more: URL $bmy"}
{"text": "rt AT_USER $bmy locks down two new deals with fellow big drugmakers URL $rhhby $biib"}
{"text": "5 things for #pharma #marketers to know: thurs, apr 13 $biib $bmy #alzheimers $aapl #healthtech #sensors #trump\u00a1\u00ad URL"}
{"text": "$bmy locks down two new deals with fellow big drugmakers URL $rhhby $biib"}
{"text": "rt AT_USER bristol-myers offloads anti-tau, dmd assets to biogen, roche for $470m; $615m in milestones: URL $bm\u00a1\u00ad"}
{"text": "rt AT_USER $bmy gets $470m u/f for licencing an anti-etau to $biib for psp and an anti-myostatin adnectin to roche for dmd. URL"}
{"text": "rt AT_USER amazing how darzalex $jnj has pulled ahead of empliciti $bmy. here's sellside consensus change over 2 years ($m), via AT_USER"}
{"text": "top #sentiment for #sp1500 #stocks at market close: $qcom $adbe $amzn $bmy $adp (2017/04/13) #stocktrading #predictiveanalytics #bigdata"}
{"text": "top sentiment for sp1500 stocks at market close: $qcom $adbe $amzn $bmy $adp (2017/04/13) #sentiment #stock #alexandria"}
{"text": "rt AT_USER #billackman should piggy-back on #carlicahn's investment in $bmy.  #bristolmyerssquibb is a prime #takeover target in\u00a1\u00ad"}
{"text": "#billackman should piggy-back on #carlicahn's investment in $bmy.  #bristolmyerssquibb is a prime #takeover target in the #biotech space."}
{"text": "rt AT_USER bristol-myers offloads anti-tau, dmd assets to biogen, roche for $470m; $615m in milestones: URL $bm\u00a1\u00ad"}
{"text": "bristol-myers squibb: looking attractive URL $mrk $bmy"}
{"text": "bristol-myers squibb: looking attractive URL $mrk $bmy"}
{"text": "$bmy #bristolmyerssquibb looking attractive at this price, for many reasons... URL"}
{"text": "rt AT_USER thanks to $bmy deal, i count six $biib alzheimer's projects, including two tau-directed antibodies. URL"}
{"text": "rt AT_USER thanks to $bmy deal, i count six $biib alzheimer's projects, including two tau-directed antibodies. URL"}
{"text": "attractive call overwrites: $shld calls more expensive than 95% of history, $chk 74%, $gdxj 72%, $bmy 70%, $aa 70%, $clf 67%, $x 67%"}
{"text": "bristol-myers squibb to out-license drugs to roche &amp; biogen for a total of $470 million in cash $bmy $biib $rhhby URL"}
{"text": "rt AT_USER thanks to $bmy deal, i count six $biib alzheimer's projects, including two tau-directed antibodies. URL"}
{"text": "#bristolmyerssquibb bristolmyers squibb enters into separate agreements with biogen and roch... read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristolmyers squibb enters into separate agreements with biogen and... read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristolmyers squibb enters into separate agreements with biogen and roch... read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristolmyers squibb enters into separate agreements with biogen and... read more: URL $bmy"}
{"text": "$bmy $pfe $gild $rog $amgn bms licensing agreements - is bristol-myers squibb raising cash to fend off potential takeover attempts?"}
{"text": "incyte +2%; morgan stanley ups price target URL $nlnk $bmy $incy #sitifatimah #malaysia #financialplanning"}
{"text": "incyte +2%; morgan stanley ups price target $nlnk $bmy $incy URL"}
{"text": "incyte +2%; morgan stanley ups price target URL $nlnk $bmy $incy"}
{"text": "incyte +2%; morgan stanley ups price target URL $nlnk $bmy $incy"}
{"text": "thanks to $bmy deal, i count six $biib alzheimer's projects, including two tau-directed antibodies. URL"}
{"text": "rt AT_USER understanding cancer immune profiles, and implications for io therapy, was a key theme at #aacr2017 $ibb $mrk $bmy URL"}
{"text": "rt AT_USER $bmy gets $470m u/f for licencing an anti-etau to $biib for psp and an anti-myostatin adnectin to roche for dmd. URL"}
{"text": "$0.74 eps expected for bristol-myers squibb co $bmy this quarter URL"}
{"text": "$0.74 eps expected for bristol-myers squibb co $bmy this quarter URL"}
{"text": "top #sentiment for #sp1500 #stocks at midday: $qcom $adbe $amzn $bmy $adp (2017/04/13) #stocktrading #predictiveanalytics #bigdata"}
{"text": "top sentiment for sp1500 stocks at midday: $qcom $adbe $amzn $bmy $adp (2017/04/13) #sentiment #stock #alexandria"}
{"text": "rt AT_USER $bmy licenses out compound for progressive supranuclear palsy to $biib, dmd to roche, for combined $470m upfront URL"}
{"text": "$bmy could snag more than $600m across two new deals URL $rhhby $biib"}
{"text": "$bmy could snag more than $600m across two new deals URL $rhhby $biib"}
{"text": "could bristol's drug help biogen take abbvie in alzheimer's? $bmy $biib $abbv $rhhby URL"}
{"text": "$0.74 eps expected for bristol-myers squibb co $bmy this quarter URL"}
{"text": "$1.1b hand off from $bmy in separate deals to biogen and roche for neurodegenerative disease programs\u00a1\u00ad URL"}
{"text": "bristol-myers squibb co gets average rating of buy from analysts $bmy URL"}
{"text": "s&amp;p100 #stocks performance $gd $amgn $msft $nee $rtn $bmy $celg $cat $fdx $jnj $pcln $mdt $dis $agn $intc  more@ URL"}
{"text": "#bristolmyerssquibb bristol-myers enters into two license deals with biogen and roche worth ... read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristol-myers enters into two license deals with biogen and roche worth ... read more: URL $bmy"}
{"text": "rt AT_USER unravelling the myriad future uses of darzalex $jnj, and how it stacks up vs empliciti $bmy. via AT_USER URL"}
{"text": "rt AT_USER unravelling the myriad future uses of darzalex $jnj, and how it stacks up vs empliciti $bmy. via AT_USER URL"}
{"text": "$bmy offloads anti-tau, #dmd assets to $biib, roche for $470m upfront, $615m in milestones #alzheimers #duchenne URL"}
{"text": "rt AT_USER amazing how darzalex $jnj has pulled ahead of empliciti $bmy. here's sellside consensus change over 2 years ($m), via AT_USER"}
{"text": "#bristolmyerssquibb bms licenses mab and fusion protein drugs to biogen and to roche, for up... read more: URL $bmy"}
{"text": "#bristolmyerssquibb bms licenses mab and fusion protein drugs to biogen and to roche, for up... read more: URL $bmy"}
{"text": "rt AT_USER unravelling the myriad future uses of darzalex $jnj, and how it stacks up vs empliciti $bmy. via AT_USER URL"}
{"text": "#bristolmyerssquibb bristol-myers offloads anti-tau, dmd assets to biogen, roche for $470m u... read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristol-myers offloads anti-tau, dmd assets to biogen, roche for $470m u... read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristol flips remnants of adnexus, ipierian to roche, biogen for $470m. read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristol flips remnants of adnexus, ipierian to roche, biogen for $470m. read more: URL $bmy"}
{"text": "5 things for #pharma #marketers to know: thurs, apr 13 $biib $bmy #alzheimers $aapl #healthtech #sensors #trump\u00a1\u00ad URL"}
{"text": "rt AT_USER unravelling the myriad future uses of darzalex $jnj, and how it stacks up vs empliciti $bmy. via AT_USER URL"}
{"text": "rt AT_USER understanding cancer immune profiles, and implications for io therapy, was a key theme at #aacr2017 $ibb $mrk $bmy URL"}
{"text": "unravelling the myriad future uses of darzalex $jnj, and how it stacks up vs empliciti $bmy. via AT_USER URL"}
{"text": "rt AT_USER amazing how darzalex $jnj has pulled ahead of empliciti $bmy. here's sellside consensus change over 2 years ($m), via AT_USER"}
{"text": "call/put highest % volume changes: calls: $bx, $mrx, $swks, $hal, $sbux. puts: $wpx, $fas, $fit, $biib, $bmy."}
{"text": "good that $bmy gets this licensing revenue URL but far more importantly hope $biib can do something to help psp patients"}
{"text": "fy2017 earnings estimate for bristol-myers squibb co issued by jefferies group $bmy URL"}
{"text": "roche, $biib handing over $470m in cash to bag two drug programs from $bmy #duchenne #dmd - URL"}
{"text": "$bmy license two drugs to $biib, roche. where is $gild?"}
{"text": "biogen is building up its alzheimer's drug arsenal with a new licensing deal $biib $bmy URL via AT_USER"}
{"text": "from AT_USER -- AT_USER pays $300m to AT_USER to license another potential #alzheimers drug URL $biib $bmy"}
{"text": "rt AT_USER #bristolmyerssquibb bristol-myers to license two of its drugs to biogen, roche. read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristol-myers to license two of its drugs to biogen, roche. read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristol-myers to get $470 mln upfront from licensing deals with biogen, ... read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristol-myers to license two of its drugs to biogen, roche. read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristol-myers to get $470 million upfront for license deals with biogen ... read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristolmyers to license two of its drugs to biogen roche. read more: URL $bmy"}
{"text": "more big #pharma out-licensing, from $bmy, peer-to-peer dealmaking URL"}
{"text": "#bristolmyerssquibb bristol-myers to get $470 million upfront for license deals with biogen ... read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristol-myers to license two drugs to biogen, roche. read more: URL $bmy"}
{"text": "rt AT_USER bristol-myers offloads anti-tau, dmd assets to biogen, roche for $470m; $615m in milestones: URL $\u00a1\u00ad"}
{"text": "#bristolmyerssquibb bristol-myers to get $470 million upfront for license deals with biogen ... read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristol-myers to license two of its drugs to biogen, roche. read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristol-myers to get $470 mln upfront from licensing deals with biogen, ... read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristol-myers to license two drugs to biogen, roche. read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristol-myers to get $470 million upfront for license deals with biogen ... read more: URL $bmy"}
{"text": "will carl icahn wait too late on valeant? will he need to cover an undislclosed  short position first? $brk $iep\u00a1\u00ad URL"}
{"text": "bristol-myers offloads anti-tau, dmd assets to biogen, roche for $470m; $615m in milestones: URL $bmy $rhhby $biib"}
{"text": "rt AT_USER interesting deal - $biib licenses anti-tau ab from... $bmy ! $300m up front URL"}
{"text": "berkshire has to be noticing/evaluating valeant w/500%+ upside to intriinsic value! $brk $iep $myl $mrk $bmy $pep\u00a1\u00ad URL"}
{"text": "$bmy bristol-myers to license two drugs to biogen, roche URL via AT_USER"}
{"text": "top #sentiment for #sp1500 #stocks at market open: $qcom $adbe $amzn $adp $bmy (2017/04/13) #stocktrading #predictiveanalytics #bigdata"}
{"text": "top sentiment for sp1500 stocks at market open: $qcom $adbe $amzn $adp $bmy (2017/04/13) #sentiment #stock #alexandria"}
{"text": "rt AT_USER bristol flips remnants of adnexus, ipierian to roche, biogen for $470m URL $bmy $biib $rhhby"}
{"text": "AT_USER AT_USER don't think big pharma $shpg $nvs $pfe $bmy $regn interest in myostatin for muscle related\u00a1\u00ad URL"}
{"text": "uncle carl hasn't made any big waves here ... yet. $bmy URL"}
{"text": "$bmy: bristol-myers agrees to license bms-986168 to biogen (biib) and bms-986089 to roche (rhhby) URL"}
{"text": "#options #maxpain chart for $bmy. free options app URL URL"}
{"text": "#bristolmyerssquibb bristol-myers squibb enters into separate agreements with biogen and roc... read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristol-myers squibb enters into separate agreements with biogen and roc... read more: URL $bmy"}
{"text": "rt AT_USER $bmy gets $470m u/f for licencing an anti-etau to $biib for psp and an anti-myostatin adnectin to roche for dmd. URL"}
